Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Calidi Biotherapeutics (CLDI)

Annual Return

Over the past 3 years, CLDI has had an average annual return of -95.50%, underperforming the benchmark SPY, which returned +19.63% annual.

Since Nov 1, 2021, CLDI has had an average annual return of -85.79%, underperforming the benchmark SPY, which returned +12.38% annual.

202620252024202320222021
-90.00%-91.53%-92.36%-85.15%+3.67%+0.31%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-10.00%-22.22%-71.43%+0%+0%-50.00%+0%-90.00%
2025-33.90%+15.38%-35.56%-15.52%-26.53%-33.33%+154.17%-77.05%-7.14%-0%+0%-23.08%-91.53%
2024-47.02%-25.43%-5.25%-65.57%-2.51%+5.15%-21.08%-27.33%+0%+3.42%+79.34%-45.62%-92.36%
2023+0.79%+0.10%+0.10%+0%+1.36%+0.77%+0.38%-12.82%-63.78%-34.44%-3.68%-28.09%-85.15%
2022+0.20%+0.21%+0.40%+0.21%-0.10%+0.41%+0.20%+0.40%-1.50%+1.01%+1.41%+0.79%+3.67%
2021+0.41%-0.10%+0.31%

Drawdown analysis of Calidi Biotherapeutics (CLDI)

The maximum drawdown for the CLDI was -99.99%, occurring on May 20, 2026. This drawdown has not yet recovered.

The current CLDI drawdown is -99.99%.

Since Nov 1, 2021 CLDI has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Aug 16, 2023692May 20, 2026OngoingOngoingOngoing
-6.62%Sep 12, 202214Sep 30, 2022198Jul 18, 2023212
-1.31%Jul 18, 20231Jul 19, 202320Aug 16, 202321
-1.21%Nov 4, 20215Nov 11, 202191Mar 24, 202296
-0.90%Jun 3, 20223Jun 8, 202259Sep 1, 202262
-0.34%Apr 25, 202212May 11, 202216Jun 3, 202228
-0.27%Mar 24, 20221Mar 25, 20225Apr 1, 20226
-0.21%Apr 1, 20222Apr 5, 202213Apr 25, 202215
-0.20%Sep 1, 20222Sep 6, 20222Sep 8, 20224